Report #2826301

Received Feb 14, 2025

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 1 yrs
State: VA
Recovered: Not recovered
Vaccinated: Feb 5, 2025
Onset: Feb 12, 2025
Days to onset: 7
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	22GP3	IM / LL
MMRV	MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)	MERCK & CO. INC.	1	Y017206	SC / LL
PNC20	PNEUMO (PREVNAR20)	PFIZER\WYETH	4	LJ5284	IM / RL

Symptoms (2)

RashRash macular

Symptom narrative

Scattered macular rash across trunk and back - onset 7 days after receiving MMRV vaccine; Diagnoses at visit on 02/14/25 Varicella without complication - B01.9 (Primary), Adverse effect of other viral vaccines, initial encounter - T50.B95A , Infection following immunization, initial encounter - T88.0XXA

Current illness

Candidiasis of skin and nail

Medical history

GERD, Facial hemangioma

Other medications

Famotidine 40 MG/5ML Suspension Reconstituted GIVE 0.3 ML BY MOUTH DAILY Nystatin 100000 UNIT/GM Cream 1 application Externally Four times a day Atenolol+SyrSpend SF 1 MG/ML Suspension 2.3 ml Orally twice a day

Allergies

NKA

Lab data

N/A - Diagnosed with varicella clinically 02/14/25